Table 2 Univariate analysis of prognosis

Conditioning

CY/TBI

HDCA/CY/TBI

1.50

(1.29–1.74)

<0.01^*

Sex

Female

Male

1.00

(0.88–1.14)

0.96

Age

≤49

≥50

1.93

(1.65–2.25)

<0.01^*

PS

0–1

≥2

2.20

(1.74–2.80)

<0.01^*

HCT-CI

≤2

≥3

1.90

(1.46–2.47)

<0.01^*

CMV sero-status

Negative

Positive

1.24

(1.04–1.48)

0.02^*

Diagnosis

AML

MDS

0.61

(0.49–0.75)

<0.01^*

Disease risk

Standard

High

2.38

(2.10–2.71)

<0.01^*

Days from diagnosis to HCT

≤240

≥241

0.89

(0.78–1.01)

0.08

Donor

Rel-BM

Rel-PB

1.16

(0.96–1.40)

0.13

UR-BM

1.11

(0.95–1.31)

0.20

HLA mismatch

Matched

Mismatched

1.25

(1.01–1.43)

<0.01^*

Sex mismatch

Matched

M to F

1.04

(0.89–1.22)

0.60

F to M

1.16

(0.99–1.36)

0.07

ABO mismatch

Matched

Minor

0.90

(0.75–1.07)

0.23

Major

1.11

(0.93–1.32)

0.23

Both

0.83

(0.64–1.07)

0.15

GVHD prophylaxis

CyA based

Tac based

1.01

(0.89–1.15)

0.87

Year of HCT

≤2008

≥2009

0.86

(0.75–0.99)

0.04^*